Tumor Tissue Implantation
Tumor Tissue Implantation - Related Videos
02:43
Tumor Implantation and Injection of a Tumor Vaccine in a Mouse Model
0 Views •
2025
This video demonstrates a cell-based tumor vaccination assay. A mouse, intradermally injected with B16-F10 melanoma cells for tumor formation, is vaccinated with B16-F10 cells secreting Flt3L cytokine near the developed tumor. The secreted Flt3L from the vaccine promotes the maturation and proliferation of dendritic cells that then present tumor antigens to T cells in lymph nodes, triggering a targeted anti-tumor immune response.
11:12
Tissue Engineering of a Human 3D in vitro Tumor Test System
0 Views •
Cited by 34 •
2013
Methods to create human 3D tumor tissues as test systems are described. These technologies are based on a decellularized Biological Vascularized Scaffold (BioVaSc), primary human cells and a tumor cell line, which can be cultured under static as well as under dynamic conditions in a flow bioreactor.
07:59
Implantation of Engineered Tissue in the Rat Heart
0 Views •
Cited by 4 •
2009
Here, we describe a cardiac surgical procedure to implant engineered tissue in the atrioventricular (AV)-groove of an adult Lewis rat.
04:34
Generating Rabbit Liver Carcinoma Model: A Surgical Procedure to Implant Tumor Tissue in Left Lobe of Liver for Induction of Hepatocellular Carcinoma
0 Views •
2025
In this video, we demonstrate the surgical implantation of tumor tissue into a rabbit liver to induce hepatocellular carcinoma. The procedure helps establish a reliable animal model to study tumor behavior and development of locoregional treatments targeting cancers of the liver.
02:31
FFPE Tumor Tissue Macrodissection: A Technique to Obtain Specific Tumorous Tissue from Unstained Specimens
0 Views •
2023
This video describes a method for the manual macrodissection of cancer tissue from unstained tissue specimens to obtain a specific cancer tissue. The tissue section can be processed further to obtain DNA for genome-wide studies on gastrointestinal cancers.
FAQs
Successful growth depends on the continued viability of cancer cells after placement and their ability to adapt to the recipient tissue or experimental model. As the implanted population develops, it establishes interactions with surrounding stromal and immune cells. These relationships influence how the tumor organizes and progresses, making the local environment an important part of the experimental system.
Blood-vessel recruitment supports the developing tumor as it adapts to its new environment. This process is studied alongside interactions with stromal and immune cells because tumor growth reflects coordinated changes in both cancer cells and surrounding tissues. Examining these relationships helps investigators interpret tumor progression as a tissue-level process rather than as cancer-cell behavior alone.
The model allows investigators to examine how viable cancer cells interact with the surrounding microenvironment during tumor development. Key observations include changes in tissue organization, recruitment of blood vessels, and relationships with stromal and immune cells. Together, these features provide evidence about how local biological interactions contribute to progression and shape the resulting tumor structure.
Implanted tumors provide a setting in which investigators can evaluate how tumors respond to cancer therapies and compare responses across experimental conditions. Differences in tumor development or treatment response can then be related to the biological behavior of the implanted tissue and its surrounding microenvironment. This supports therapeutic development by connecting experimental treatment outcomes with tumor biology.
The central workflow is to obtain viable tumor fragments, place them into a selected recipient tissue or experimental model, and study their development over time. The implanted material must retain living cancer cells capable of adapting to the new setting. Subsequent analysis can focus on growth, tissue organization, blood-vessel recruitment, and cellular interactions within the developing tumor.
This approach is useful when a study requires more than an isolated examination of cancer cells. It can address tumor progression, tissue organization, and interactions between tumor cells and the microenvironment in an experimental setting. Researchers may also select it when they need to evaluate cancer therapies or compare treatment responses using developing implanted tumors.
These models can provide experimental evidence about how tumors develop within a surrounding tissue context. Investigators may assess progression, organization, recruitment of blood vessels, and interactions with stromal or immune cells, while treatment studies can reveal differing therapeutic responses. Such findings help connect observable tumor behavior with broader questions in tumor biology and therapeutic development.